Lifeboat Foundation

A team of researchers in the Faculty of Engineering of The University of Hong Kong (HKU) has developed a coin-sized system that can read weak electrochemical signals and can be used for personalized health monitoring and the measurement of such conditions as diabetes, cardiovascular diseases and mental health. The discovery was featured on the cover of Analytical Chemistry.

The PERfECT System—an acronym for Personalized Electronic Reader for Electrochemical Transistors—is the world’s smallest system of its kind, measuring 1.5 cm x 1.5 cm x 0.2 cm and weighing only 0.4 gram. It is easily wearable, for instance integrated with a smartwatch or as a patch, to allow for continuous monitoring of biosignals such as glucose levels and antibody concentrations in blood and even sweat.

Continue reading “Coin-sized wearable biosensing platform for digital health” »

Researchers at Aalto University have developed a bio-based adhesive that can replace formaldehyde-containing adhesives in wood construction. The main raw material in the new adhesive is lignin, a structural component of wood and a by-product of the pulp industry that is usually burned after wood is processed. As an alternative to formaldehyde, lignin offers a healthier and more carbon-friendly way to use wood in construction.

The carbon footprint of timber construction is significantly lower than concrete construction, and timber construction has often been viewed as better for the health of human occupants as well. However, wood panels still use adhesives made from fossil raw materials. They contain formaldehyde, which can be harmful to health, especially for those working in the adhesive manufacturing process. People living in or visiting buildings can also be exposed to toxic formaldehyde from wood panels.

Lignin, on the other hand, comes from wood itself. It binds cellulose and hemicellulose together and gives wood its tough, strong structure. Lignin accounts for about a quarter of the weight of wood and is produced in huge quantities in the pulp and bioprocessing industry. Only two to five percent of the lignin produced is used, and the rest is burned in factories for energy.

Agility Robotics recently raised $150 million USD in part from Amazon to further develop its humanoid robot called “Digit” for logistics automation. New wearable, bendable, stretchable neuromorphic AI chip monitors health in real time. New machine learning model from MIT does college level math at a human level.

AI News Timestamps:
0:00 Humanoid Robot Worker For Amazon Automation.
3:00 New Wearable AI Chip.
5:08 New Machine Learning Math Model.

Continue reading “Humanoid Robotics For Amazon Automation | New Wearable AI Chip | New Machine Learning Math Model” »

An Israeli company has launched a clinical trial to determine if its innovative microbiome-based therapeutic could increase the responsiveness of some cancer patients to immunotherapy.

The microbiome is gut bacteria – trillions of microorganisms that live in the intestinal tract and play a role in digestion, immunity and many other aspects of health.

Rehovot-based Biomica, a subsidiary of Evogene, dosed its first patients in a Phase I clinical trial at Rambam Health Care Campus last month with a new drug – BMC128 – that is expected to help patients who do not respond to immunotherapy. Specifically, the company hopes the trial will demonstrate the safety, tolerability and preliminary clinical effectiveness of its BMC128 microbiome-based immuno-oncology drug candidate in combination with immune checkpoint inhibitor (ICI) immunotherapy.

Comotion_design/iStock.

The U.S. Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative is a collaboration among the National Institutes of Health, Defense Advanced Research Projects Agency, National Science Foundation, Food and Drug Administration, Intelligence Advanced Research Projects Activity, and others. Since its inception in 2013, its goal has been to develop and use new technologies to examine how each neuron and neural circuit come together to “record, process, utilize, store, and retrieve vast quantities of information, all at the speed of thought.”

The FDA will allow health-care providers to administer the shots through intradermal injection, or between the layers of the skin, for adults.

The space between the planets in our solar system is filled with a wispy sea of charged particles that flow out from the Sun’s atmosphere. This particle population is augmented by cosmic rays — speedy protons and atomic nuclei accelerated in extreme environments across the universe — which ebb and flow against the 11-year solar activity cycle. This undulating particle background is punctuated by bursts of high-energy particles from the Sun, which can be unleashed suddenly in violent solar storms.

Spacecraft that venture out from the protection of Earth’s magnetic field must navigate this ocean of particles and weather solar storms. And if we someday wish to send astronauts to other planets, we’ll need to know how high-energy solar particles, which pose a risk to the health of astronauts and electronic systems alike, travel through the solar system.

In a new publication, a team led by Shuai Fu (Macau University of Science and Technology), Zheyi Ding (China University of Geosciences), and Yongjie Zhang (Chinese Academy of Sciences) studied the high-energy solar particles produced in an event in November 2020, when the Sun emitted a solar flare and a massive explosion of solar plasma called a coronal mass ejection.

Science, Technology, Health, Physics, Chemistry stay Updated.

Scientists from The Australian National University (ANU) and James Cook University (JCU) have identified an “exquisite” natural mechanism that helps plants limit their water loss with little effect on carbon dioxide (CO₂) intake—an essential process for photosynthesis, plant growth and crop yield.

In a first-of-its-kind gathering at the New York Academy of Sciences, researchers from some of the world’s leading universities and institutions convened to discuss at the 13th annual Key Symposium the various applications of bioelectronic medicine, the cutting-edge field that uses technology to treat disease and injury. While still in early stages of development, bioelectronic medicine has already been proven in studies and clinical trials to successfully treat conditions including paralysis and rheumatoid arthritis.

This panel, moderated by Miles O’Brien from PBS’ NewsHour, discusses what life will be like when we can fully modulate the nervous system and the impact that would have on disease, drugs, the healthcare industry, personal freedom, and privacy. The panel includes Polina Anikeeva, PhD, from the Massachusetts Institute of Technology, Chad Bouton from The Feinstein Institute for Medical Research at Northwell Health, Peder S. Olofsson, MD, PhD, from the Karolinska Institutet, and Doug Weber, PhD, from the U.S. Defense Advanced Research Projects Administration.

Continue reading “What Life Will be Like with Bioelectronic Medicine” »